China new bank loans rise in May, but well below forecasts
Chinese banks extended 950 billion yuan ($130.93 billion) in new yuan loans in May, rising from April but missing analysts’ expectations.
In pictures: India records ‘longest’ heatwave, Delhi faces water crisis
India’s capital Delhi is facing a severe water crisis as the country undergoes its “longest spell” of recorded heatwave.
Chinese automakers overtake U.S. rivals in sales for the first time, report shows
Chinese carmakers, like BYD, have expanded globally as an electric-vehicle price war at home has pushed down prices and weighed on profit margins.
CNBC Daily Open: Mega money Musk, Kitty’s stake grows
Tesla shareholders voted to ratify CEO Elon Musk’s 2018 pay plan at the annual meeting, despite a Delaware judge ordering its rescission five months earlier.
China needs bond market reforms to rein in soaring debt, S&P Global says
Despite government efforts, debt levels continue to surge even as nominal GDP growth has slowed down, the rating agency said in a report on Thursday.
Ukraine’s peace summit lacks clout as Russia, China and others stay away
Ukraine’s leadership has been talking about this weekend’s peace summit in Switzerland for months, trying to drum up enthusiasm for Kyiv’s peace plan.
Toyota has been rocked by a string of scandals — but analysts are unfazed
Given the recent scandals, will investors flee the stock, preferring to sink money in other scandal-free Japanese automakers instead?
Bank of Japan set to reduce JGB purchases, stands pat on interest rate
The BOJ said it will collect views from market participants on the reduction of Japanese government bond buying and present a detailed plan in the next meeting.
This fintech configures expense cards to block misuse — and investors just backed it with millions
Irish fintech CleverCards uses a digital platform linked to configurable expense cards to give companies control over how employees use their corporate cards.
Brain science start-up Neuroelectrics uses electricity and a headcap to reduce seizures in patients with epilepsy. Now it needs FDA approval
Neuroelectrics is developing therapies it says will improve the lives of people living with brain disease.
